The latest oncology treatment & supportive care news
Selpercatinib was granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration in 2018…
Acute myeloid leukaemia (AML) has one of the worst prognosis of all leukaemias. Its treatment with chemotherapy…
Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to…
Results from a new study indicate that older hospitalised patients with cancer may have a…
A new study gives insight into how immunotherapies, treatments that help the body’s immune system…
Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially…
By Monique Biryiana In 2018, prostate cancer was the second most common cancer in men,…
A new large population-based study shows that novel oral androgen signalling inhibitor therapies are associated…
An international survey of more than 4000 cancer patients and carers, including 850 Australians, has…
It’s well known that keeping blood glucose levels in check can help individuals avoid or…